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ABSTRACT 
Xiaojia Wang. CIRCADIAN ACTIVATION OF MAST CELLS MEDIATES THE 
NOCTURNAL RESPONSE IN ALLERGIC ASTHMA (under the direction of Michael R. 
Van Scott, Ph.D.) Department of Physiology, July 23, 2010 
 
Circadian rhythm is a conserved physiological feature of most organisms. Nocturnal 
symptoms are a common feature of allergic asthma in humans.  Patients with nocturnal 
asthma show circadian variation of their pulmonary function and inflammation, but 
nocturnal asthmatic responses have not been documented in animal models.  In this 
study we tested the hypotheses that house dust mite (HDM) allergen-sensitive 
nonhuman primates (NHP) manifest nocturnal symptoms, and whether intrinsic 
circadian activity in mast cells might underlie nocturnal asthma response.  Dynamic 
compliance (Cdyn) and lung resistance (RL) measured as indicators of 
bronchoconstriction in anesthetized NHP, at rest and following exposure to HDM 
allergen, methacholine, and albuterol, were highly correlated with 3 respiratory inductive 
plethysmography (RIP) parameters: Phase Angle of the rib cage and abdomen 
waveforms (PhAng), Baseline Effort Phase Relation (eBPRL) and Effort Phase Relation 
(ePhRL). 21 allergic subjects were challenged with HDM early in the morning, and 
eBPRL and ePhRL were monitored for 20 hours after provocation. 15 of the allergic 
subjects exhibited gradual increases in eBPRL and ePhRL between midnight and 6 AM, 
with peak activity at 4 AM. The results demonstrate that animals exhibiting acute 
responses to allergen exposure during the day also exhibit nocturnal airway obstruction, 
possibly resulting from bronchoconstriction.  Mast cells are central effector cells in 
asthma, and were subsequently investigated for intrinsic circadian activity that could 
  
underlie nocturnal asthma responses.  Bone marrow derived mast cells (BMMCs) were 
exposed to high concentrations of serum (serum shocked) to synchronize gene 
expression.  Following serum shock, circadian genes (mPer2, Bmal1, Rev-erbα, and 
Dbp) exhibit oscillations for up to 72 hours. Likewise, the high affinity IgE receptor in 
BMMCs (FcεRIα) exhibited circadian expression.  The fcer1a gene and FcεRIα protein 
following serum shock exhibited mean periods of 18.9 and 28.6 hours, respectively. 
Synchronized BMMCs stimulated with IgE/Ag at different circadian time display 
circadian rhythms in IL-13 mRNA.  Taken together, synchronized BMMCs suggest an 
underlying circadian mechanism of nocturnal asthma in vitro.  
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CHAPTER 1:  INTRODUCTION 
 
Allergic Asthma 
Traditionally, asthma is divided into two general categories: the non-allergic 
(intrinsic) asthma and the allergic (extrinsic) asthma, depending upon the types of 
stimuli that trigger attacks. The non-allergic asthma is not allergy-related and is caused 
by inhalation of chemicals while the allergic asthma is triggered by allergen. The 
immunopathology of non-allergic asthma appears to be very similar to that of allergic 
asthma. However, there have been some differences reported in the relative proportion 
of the various inflammatory cells presents. The non-allergic asthma has been subject to 
careful comparative investigation but so far no clear pathogenic pathways have been 
identified (Humbert et al., 1999; Corrigan, 2004; Holgate, 2008). 
Allergic asthma is one of the most common diseases in developed countries, with 
an incidence of approximately 8% in the USA (2007).  Allergic asthma is a chronic 
inflammatory disorder of the airways in which many cell types and cellular elements play 
a role (2002).  Chronic inflammation in asthma patients causes an airway 
hyperresponsiveness (AHR) that leads to an episodic coughing, shortness of breath, 
and/or wheezing particularly at night and in the early morning (2002).  
The development of allergic asthma is classified into three phases: sensitization, 
the early-phase asthmatic responses (EARs) and the late-phase asthmatic responses 
(LARs).  
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Sensitization 
Sensitization is initiated by an initial inhalation of an allergen. The majority of 
allergen inhaled in the airways is cleared by the mucocililary escalator (Verstraelen et 
al., 2008).  However, the escaped allergen can be sampled by dendritic cells (DCs) in 
the airway lumen or can enter tissues through disrupted epithelium.  Also, the airway 
epithelium tight junctions can be cleaved by allergens with protease activity, such as 
house dust mite (HDM) (Galli et al., 2008). The allergen that passed through the 
epithelial lining in the airway is taken up by antigen-presenting cells (APCs), including 
DCs, macrophages, and B cells (Holt, 2000).  APCs process the allergen in the local 
respiratory tract mucosa or in regional lymph nodes, and then present small peptides, 
bound to a class II major histocompatibility complex (MHC) on their membranes.  After a 
T helper (TH) cell recognizes and interacts with an antigen-MHC class II molecule 
complex, the TH cell is activated and becomes a Type 2 effector cell, TH2, which 
secretes the canonical cytokines interleukin (IL)-4, IL-5, and IL-13. The secreted 
cytokines drive IgE production by promoting immunoglobulin class-switch recombination 
in B cells (Gould et al., 2008).  After release into the blood, IgE binds to the high-affinity 
receptor, FcεRI, on the surface of mast cells or basophils, to prime them to respond to 
subsequent re-exposure to allergen. 
 
EARs 
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EARs occur within minutes following re-exposure to allergen.  Antigen-induced 
crosslinking of adjacent IgE and aggregated FcεRI on the surface of pulmonary mast 
cells results in immediate release of preformed inflammatory mediators including 
histamine, tryptase, tumor-necrosis factor-α (TNF-α), and newly synthesized mediators 
such as prostaglandin and leukotriene (Galli et al., 2005; Verstraelen et al., 2008; Brown 
et al., 2008a).  The immediate release of mediators contributes to bronchoconstriction 
by inducing airway smooth muscle contraction and increased goblet cell and tubulo-
acinar gland mucus production and secretion into the airway (Bradding, 2003), leading 
to increased airway resistance and decreased lung compliance.  Such symptoms are 
associated with early-phase asthmatic reactions.  In addition to the mediators produced 
by mast cells, the recently described cytokine, thymic stromal lymphopoietin (TSLP), is 
released by pulmonary epithelial cells and also promotes the TH2 response (Allakhverdi 
et al., 2007; Corrigan et al., 2009). 
 
LARs 
The late-phase asthmatic responses (LARs) occur 4-6 hours after antigen 
provocation and can be prolonged for over 7 days. During LARs, early IgE/Antigen (Ag) 
activated mast cells release newly synthesized cytokines, such as IL-4, IL-5, IL-13, 
granulocyte macrophage-colony stimulating factor (GM-CSF), and macrophage 
inflammatory protein-1α (MIP-1α), which recruit, prime, and activate inflammatory cells 
(Galli et al., 2008).  These inflammatory cells, including eosinophils, neutrophils, and 
CD4+ T cells, can release more cytokines, chemokines, and lipid mediators, which 
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induce airway bronchoconstriction, enhance mucus production, and increase airway 
responses to nonspecific bronchoconstrictors, such as methacholine.   
TH2 cells also play a very important role in LARs. Researchers have shown that 
allergic asthma predominantly results from an imbalance in favor of a TH2 response.  
Allergen specific TH2 cells are present in the lungs of almost all patients with asthma, 
particularly patients with allergic asthma (Kim et al., 2010).  TH2 cells produce cytokines 
that regulate IgE synthesis (IL-4), recruit eosinophils (IL-5), recruit and develop mast 
cells (IL-9), and increase AHR (IL-13). TH2 responses induce chronic eosinophil 
predominant inflammation in the airway, which is characteristic of LARs (Verstraelen et 
al., 2008). One of the most common features in LARs is recurrent nocturnal 
bronchoconstriction, airway inflammation, AHR, dyspnea, cough and apnea (Ballard et 
al., 1989; Kraft et al., 1999b; Irvin et al., 2000; Kelly et al., 2004; Smolensky et al., 
2007).  
 
Circadian Rhythm 
The word “circadian” is from the Latin “circa” (approximately) and “diem” (a day).  
The physiology and behavior of most organisms from cyanobacteria to humans display 
a circadian rhythm, i.e., physiological processes and behavior oscillate with a periodicity 
of approximately 24 hours.  Circadian rhythm is governed by an internal circadian timing 
system and is entrained by environmental cues (such as light, temperature, and 
magnetic field) (Dibner et al., 2010; Paschos et al., 2010). In mammals, the circadian 
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timing system consists of three components: sensors, pacemakers, and effectors.  
Sensors include both photic and non-photic receptors that entrain the central clock to 
environmental cues. Photic receptors located at the retina of the eye receive photic 
information from the environment and transmit information as neurotransmitters via 
axons of the retinohypothalamic tract (RHT) to the central clock, whereas non-photic 
information transmits to the suprachiasmatic nucleus (SCN) through the 
geniculohypothalamic (GHT), dorsal raphe nucleus (DRN) and median raphe nucleus 
(MRN). The master central pacemaker located in the SCN of the ventral hypothalamus 
(Gekakis et al., 1998) generates an oscillation with a periodicity of about 24 hours and 
sends its rhythmic information to synchronize effectors via a variety of outputs.  
Peripheral organs, known as effectors, have been discovered to maintain circadian 
clocks (Schibler et al., 2003; Cermakian et al., 2009). A peripheral clock presents in 
lung (Gibbs et al., 2009), liver (Akhtar, 2001), kidney (Wang et al., 2006), adipose 
tissue(Wu et al., 2007) and blood cells(Boivin et al., 2003) and also exists in various 
non-SCN brain regions, such as hypothalamic nuclei, paraventricular nucleus (PVN), 
olfactory bulb and pineal gland(Abe et al., 2002).  
 
Circadian Central Clock 
The circadian central clock resides in the SCN which thus plays a prominent role 
in circadian rhythmicity.  The SCN is a paired neuronal nucleus located on both sides of 
the third ventricle, just above the optic chiasm (Abrahamson et al., 2001).  Complete 
lesions of SCN abolish circadian rhythmicity in physiological and behavioral parameters 
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(Welsh et al., 2010; Chiesa et al., 2010; Angeles-Castellanos et al., 2010).  
Transplantation of SCN tissue into SCN lesions in animals can partially restore their 
circadian rhythm activity (LeSauter et al., 1997).  SCN neurons cultured in vitro maintain 
their circadian firing oscillation up to three weeks, which is partially mediated by 
circadian regulation of membrane potassium channels (Kuhlman et al., 2006; Welsh et 
al., 2010).  The neuronal cells in the SCN communicate through paracrine and synaptic 
secretions to synchronize themselves when mammals are deprived of external timing 
cues (Dibner et al., 2010). Therefore, the SCN contains the master clock in mammals 
and SCN neuronal firing coordinates the circadian oscillation in peripheral organs.  
 
Circadian Peripheral Clock 
Circadian clocks are present not only in the SCN but also in most peripheral 
organs (Akhtar, 2001; Boivin et al., 2003; Wang et al., 2006; Wu et al., 2007; Gibbs et 
al., 2009).  Numerous physiological functions in peripheral organs are subject to 
circadian oscillation.  In humans, pulmonary function, including tidal volume, minute 
ventilation, mean inspiratory flow, et al., exhibit circadian variations (Adamczyk et al., 
2008).  Cardiovascular function, including heat rate and blood pressure, vary over 24 
hours (Takeda et al., 2010).  Circadian rhythms have a profound influence on immune 
function (Esquifino et al., 2007), including lymphocyte proliferation and cytokine 
production.  Immune cells, such as peripheral blood mononuclear cells (PBMCs) (Born 
et al., 1997; Murphy et al., 2007), natural killer (NK) cells (Arjona et al., 2006), and 
7 
 
peritoneal macrophages, have been found to exhibit circadian rhythmicity (Keller et al., 
2009).  
Circadian oscillators are also self-sustained in established cell lines (Nagoshi et 
al., 2004) and some primary cells (Keller et al., 2009).  However, circadian oscillation in 
individual cells that are not entrained to an external signal is uncoordinated, and 
therefore self-sustained oscillation in populations of cells is unsynchronized. Detuned 
circadian oscillators in cells can be synchronized by a serum shock (Balsalobre et al., 
1998; Nagoshi et al., 2004; Durgan et al., 2005) or a variety of pharmacological 
substances including cAMP analogs, glucocorticoids, and dexamethasone (Balsalobre 
et al., 2000a; Wu et al., 2007; Wu et al., 2008; Huang et al., 2009; Yagita et al., 2010).   
 
Circadian Molecular Clock 
The molecular aspects of the circadian clock are similar in SCN and peripheral 
organs.  The core circadian molecular clock in mammals consists of a series of delayed 
transcriptional and translational feedback loops  involving Period1-3, Clock, Bmal1, and 
Cry1-2 genes (Takahashi et al., 2008).  CLOCK and BMAL1 heterodimers translocate 
into the nucleus, binding to E-box motifs (CACGTG), and activate transcription of Per 
and Cry genes (Gekakis et al., 1998).  PER and CRY proteins are synthesized in the 
cytoplasm, accumulate to a critical level, and bind to CKIε/δ kinase.  The 
phosphorylated heterotrimers translocate into the nucleus, and inhibit the CLOCK-
BMAL1 heterodimers, thereby inhibiting transcription of their own genes as well as other 
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clock controlled genes (CCGs) (Kume et al., 1999). Clock control genes encode a 
variety of proteins including transcription factors, metabolic enzymes, and receptors 
(Ganguly et al., 2007; Cai et al., 2008; Marcheva et al., 2010).  Another feedback loop 
directs alternating activation and repression of BMAL1 expression by the nuclear 
receptors RORα and REV-ERBα(Etchegaray et al., 2003) respectively(Sato et al., 2004; 
Emery et al., 2004).  The period for finishing entire transcriptional and translational 
feedback loops is approximately 24 hours. 
 
Mast Cell 
 Mast cells arise from CD34+ pluripotential progenitor cells, circulate in the blood, 
and mature upon entering tissues (Brown et al., 2008a). Mast cells, involved in both 
innate immune response and adaptive immune responses, reside in the connective 
tissue and in the mucous membranes. Mast cells play an important role in tissue 
homeostasis, wound healing, host defense to pathogens, autoimmune disease, and 
allergic inflammation (Abraham et al., 2010). A common morphological feature of mast 
cells is prominent granules in their cytoplasm which contain preformed mediators 
including histamine, proteases, and cytokines.  Diseases associated with mast cells 
include extrinsic mast cell disorders, such as IgE-mediated allergic disorders acting 
through FcεRI receptors on mast cells or direct mast cell activators acting through other 
receptors, and intrinsic mast cell disorders, such as mastocytosis and monoclonal mast 
cell activation syndrome (Stone et al., 2010).  
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 The mast cell is a crucial effector cell in the pathophysiology of allergic asthma 
(Brown et al., 2008a).  In allergic asthmatics, the infiltration of mast cells into the airway 
causes a significant increase of cell numbers within the bronchial epithelium (Pesci et 
al., 1993) and the airway smooth muscle bundles (Brightling et al., 2002; Carroll et al., 
2002; Brightling et al., 2005). The localization of mast cells within the bronchial 
epithelium in asthmatics will facilitate activation of mast cell by exposure noxious stimuli 
such as allergen (Bradding et al., 2006). Repeated exposure to allergen leads to 
crosslinking of IgE which binds to the FcεRI on the surface of mast cells by allergen, 
which triggers a complex activation of signaling cascades and causes mast cell 
degranulation (Metcalfe et al., 2009), releasing the granule contents, including 
histamine, tryptases, chymases, and proinflammatory cytokines (TNF-α), into the 
external cellular environment.  The released mediators induce airway smooth muscle 
contraction and mucus production, which contribute to the early asthmatic response.   
Mast cells responding to IgE/Ag also release numerous newly synthesized cytokines, 
chemokines, and growth factors. These mediators are released more slowly than the 
preformed mediators, however.  The synthesized mediators induce airway constriction, 
enhance AHR, increase mucus secretion, and recruit inflammatory cells, such as 
eosinophils, neutrophils, and lymphocytes, into the airways several hours following 
allergen challenge (Verstraelen et al., 2008).  Such signs and symptoms are associated 
with the late asthmatic response.  
The localization of mast cells within the airway smooth muscle bundles in 
asthmatics will facilitate interaction between mast cells and smooth muscles cells 
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through localized mediator release and direct cell-cell communicate, and thus will cause 
hypertrophy and hyperplasia of airway smooth muscle  (Bradding et al., 2006). Airway 
smooth muscle dysfunction will result in AHR to non-specific stimulus and airway 
obstruction. 
 
FcεRI 
 A hallmark of mast cells is expression of the high affinity IgE receptor, FcεRI, on 
their cell surface (Gregory et al., 2006). FcεRI is a heterotetrameric receptor composed 
of an α-subunit, a β-subunit, and two identical disulfide-linked γ-subunits (Kalesnikoff et 
al., 2008).  The α-subunit consists of two 90-aa extracellular domains, which bind to the 
CH3/CH3 and CH4/CH4 domains of IgE, a transmembrane domain, and a short 
cytoplasmic tail.  The β-subunit spans the plasma membrane four times with a single 
immunoreceptor tyrosine-based activation motif (ITAM) and links the α subunit to the γ 
homodimer. The two γ subunits extend a considerable distance into the cytoplasm, and 
each subunit has an ITAM in its cytosolic domain which is important for initiating the 
downstream signaling events of FcεRI.  Allergen mediated crosslinking of the bound IgE 
results in aggregation of the FcεRI receptors on the surface of mast cells and rapid 
tyrosine phosphorylation by Lyn kinase in the ITAMs of the β and γ subunits, which 
initiates the process of degranulation and synthesis of new mediators in mast cells.  
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Nocturnal Asthma 
As mentioned above, nocturnal asthma is a component of the LAR and exhibits a 
circadian rhythm.  The nocturnal asthmatic response (NAR) is characterized by 
bronchoconstriction, airway inflammation, dyspnea, wheezing, and cough associated 
with a decreased quality of sleep and an increased mortality during the night (Turner-
Warwick, 1988; Kondo, 1993).  
 
Epidemiology of Nocturnal Asthma 
In 1988, Turner-Warwick surveyed 7729 asthmatic patients and reported that 
74% awoke at least once a week due to bronchoconstriction, dyspnea, apnea, or cough. 
Sixty-four percent had nocturnal symptoms at least three times per week (Turner-
Warwick, 1988).  In 1994, Storms et al. reported that 67% of  325 subjects had 
nocturnal symptoms with 11% awakening every night and 16% awakening three to six 
nights per week  (Storms et al., 1994).  In 1971, Cochrane and Clark reported that 68% 
of deaths attributed to asthma in Greater London hospitals occurred between midnight 
and 8 AM (Cochrane et al., 1975).  
 
Lung Function 
Although lung function has been shown to fluctuate over 24 hours in non-
asthmatics, these fluctuations are much more obvious in asthmatic patients with 
nocturnal symptoms (Smolensky et al., 2007).  In patients with nocturnal asthma,  
differences in forced expiratory volume in one second (FEV1) exceeding 15% and 
decreases in peak expiratory flow rate (PEFR) have been shown between bedtime and 
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awakening (Martin et al., 1990; Martin, 1999; Sutherland, 2005). In addition to increases 
in airway obstruction in nocturnal asthmatics during sleep, pronounced reductions in 
functional residual capacity (FRC) have been observed (Ballard et al., 1990).  Alteration 
of physiologic interaction between the airways and lung parenchyma has been reported 
in nocturnal asthma. During sleep, an immediate uncoupling of the parenchyma to the 
airway has been found in nocturnal asthmatics, associated with significant increases in 
lower airway resistance, decreases in FRC, and decreases in respiratory system 
compliance (Irvin et al., 2000).  Even though FRC restored to presleep values in 
nocturnal asthmatics, lower airway resistance did not significantly fall due to the 
decreases in respiratory system compliance.  
 
Airway Inflammation 
 Airway inflammation in nocturnal asthmatics has been shown to oscillate over 
24h with intensifying symptoms during the sleep period. Studies have shown the 
concentration of histamine (Jarjour et al., 1992) and the numbers of eosinophils, 
neutrophils (Martin et al., 1991), and macrophages (Kelly et al., 2004) in 
bronchoalveolar lavage (BAL) fluid were significantly greater at 4 am than those at 4 pm 
in nocturnal asthmatics. Other studies by Kraft et al. have shown that numbers of 
eosinophils in the bronchial airway tissue and CD4+ T cells in the alveolar tissue were 
significantly higher at 4 AM in nocturnal asthmatics than in asthmatic without nocturnal 
symptoms (Kraft et al., 1996; Kraft et al., 1999a). 
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Goal of Research and Statement of Hypothesis 
Both pulmonary function and airway inflammation have shown circadian 
rhythmicity in nocturnal asthmatics, implicating that a circadian timing system may play 
a significant role in nocturnal asthma. However, whether the circadian timing system 
itself actually induces and/or exacerbates nocturnal asthma, and by what mechanisms, 
remains to be more fully elucidated.  
The goal of my current research was to test the hypothesis that nocturnal 
symptoms in asthma are a fundamental characteristic of the disease manifested in both 
humans and animals, and arise from circadian clock activity in mast cells. Since 
circadian rhythm exists in almost all organisms, nocturnal asthmatic symptoms in 
humans might also present in HDM-sensitive NHP.  Furthermore, cells associated with 
asthma, such as mast cells, might exhibit circadian gene oscillation and the circadian 
clock in these cells might regulate their functions.  
 
Specific Aims: 
Aim 1: Test the hypothesis that aerosol allergen exposure elicits a delayed, nocturnal 
response in HDM-sensitive NHP.   
  
 Aim 1.1 Identify respiratory inductive plethysmography (RIP) parameters which 
are highly correlated with conventional measures of lung resistance (RL) and dynamic 
compliance (Cdyn).  
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 Aim 1.2 Determine the nocturnal response in HDM-sensitive NHP by RIP 
measurement.  
 
Aim 2:  Test the hypothesis that a circadian clock expressed in murine bone marrow 
derived mast cells (BMMCs) modulates IgE-dependent activation in vitro (Figure 1.1). 
 
 Aim 2.1 Demonstrate circadian clock gene expression in BMMCs following serum 
shock 
 Aim 2.2 Test whether activation of BMMCs display a circadian pattern (IgE-
dependent and IgE-independent) 
 
 Aim 2.3 Determine the influence of BMMC activation on circadian clock gene 
expression 
 
 Aim 2.4 Examine whether IgE dependent circadian activation of BMMCs is due to 
circadian expression of IgE receptor (FcεRIα) 
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Figure 1.1 Proposed intrinsic circadian clock in mast cell 
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CHAPTER 2:  NOCTURNAL THORACOABDOMINAL ASYNCHRONY IN THE 
HOUSE DUST MITE SENSITIVE NONHUMAN PRIMATES 
PUBLISHED:  Wang et al. Journal of Asthma and Allergy 2010: 3 75-86 
SUMMARY 
Nocturnal bronchoconstriction is a common symptom of asthma in humans, but 
is poorly documented in animal models. Thoracoabdominal asynchrony (TAA) is a 
noninvasive clinical indication of airway obstruction. In this study, respiratory inductive 
plethysmography (RIP) was used to document nocturnal TAA in house dust mite (HDM) 
sensitive Cynomolgus macaques. Dynamic compliance (Cdyn) and lung resistance (RL) 
measured in anesthetized animals at rest and following exposure to HDM allergen, 
methacholine, and albuterol, were highly correlated with 3 RIP parameters associated 
with TAA: Phase Angle of the rib cage and abdomen waveforms (PhAng), Baseline 
Effort Phase Relation (eBPRL) and Effort Phase Relation (ePhRL). 21 allergic subjects 
were challenged with HDM early in the morning, and eBPRL and ePhRL were 
monitored for 20 hours after provocation. 15 of the allergic subjects exhibited gradual 
increases in eBPRL and ePhRL between midnight and 6 AM, with peak activity at 4 AM. 
However, as in humans, this nocturnal response was highly variable both between 
subjects and within subjects over time. The results document that TAA in this 
nonhuman primate model of asthma is highly correlated with Cdyn and RL; and 
demonstrate that animals exhibiting acute responses to allergen exposure during the 
day also exhibit nocturnal TAA.  
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INTRODUCTION 
Allergic asthma is a common disease in developed countries, with an incidence 
of approximately 8% in the USA (2007).  Nocturnal symptoms of asthma are common 
and include bronchoconstriction, airway inflammation and hyperreactivity, dyspnea, 
cough, and apnea (Ballard et al., 1989; Kraft et al., 1999b; Irvin et al., 2000; Kelly et al., 
2004; Smolensky et al., 2007).  The incidence and magnitude of nocturnal asthma is 
variable.  Approximately 70% of asthmatics experience nocturnal symptoms at least 
once per week, and 10% experience nocturnal symptoms at least 3 times per week 
(Turner-Warwick, 1988).  Nocturnal symptoms can be severe, and a high incidence of 
respiratory arrest and deaths due to asthma is seen between midnight and 8 AM 
(Cochrane et al., 1975; Hetzel et al., 1977; Weitzman et al., 1998).  The mechanisms 
underlying nocturnal asthma have not been elucidated. 
 Early and late asthmatic responses are routinely investigated using animal 
models, but nocturnal symptoms are poorly documented in these models due in part to 
the nocturnal nature of rodents and to the techniques commonly used to assess 
bronchoconstriction in larger diurnal laboratory animals.  Respiratory inductive 
plethysmography (RIP) is a noninvasive technique for monitoring breathing 
patterns(Pennock et al., 1979; Abraham et al., 1981; Tobin et al., 1983; Whyte et al., 
1991; Cantineau et al., 1992; Rusconi et al., 1995; Springer et al., 1996; Stromberg et 
al., 1996a; Millard, 1999; Miller et al., 2000; Kaplan et al., 2000; Kohyama et al., 2001; 
Black et al., 2004; Willis et al., 2004; Brown et al., 2008b; Hammer et al., 2009) and 
may be applicable to nocturnal studies in large animals.  RIP uses deflection of the 
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ribcage and abdomen to estimate changes in lung volume, airflow, and phase 
relationship of abdominal and thoracic movements.  Restricting airflow through the 
airways causes movements of the thorax and abdomen to be out of phase, giving rise to 
thoracoabdominal asynchrony (TAA).  TAA is a common clinical indicator of airway 
obstruction (Ringel et al., 1983; Sackner et al., 1984; Hillman et al., 1986; Rusconi et 
al., 1995; Litman et al., 2002; De et al., 2002), and in this study is used to detect 
nocturnal respiratory disturbances. 
Nonhuman primates (NHP) exhibit a high level of similarity to humans in genetic, 
anatomic, and physiological aspects, and are well suited to modeling human diseases 
(e.g. asthma) (Coffman et al., 2005).  The HDM model of allergic asthma in Cynomolgus 
macaques (referred to subsequently as “the NHP model”) reproduces the key features 
of human asthma, including elevated serum IgE levels, β-agonist reversible 
bronchoconstriction, and late phase eosinophilic inflammation (Van Scott et al., 2004).  
In addition, the airways become hyperresponsive to nonspecific bronchoconstrictors 
including histamine, methacholine, and adenosine (Van Scott et al., 2004; Van Scott et 
al., 2005). CD4+ T-lymphocytes and NKT cells in BAL fluid are increased, and Th2 
lymphocyte cytokines are up-regulated (Ayanoglu et al., 2010).  The severity of the 
asthma phenotype in the NHP model depends on the schedule of allergen challenges 
and the provocative dose of dust mite.  At an exposure periodicity of 4 to 6 week 
intervals as used in this study, the animals have minimal symptoms between exposures, 
but on the day of provocation, exhibit a severe acute asthmatic response, including 
decrease in arterial O2 saturation to less than 80% and in some animals less than 70%.  
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Upon resolution of the acute response the animals develop eosinophilia that is 
equivalent to what is observed following segmental allergen challenge of asthmatic 
humans (Erpenbeck et al., 2006).  As in humans, the symptoms are attenuated with 
corticosteroids (Van Scott et al., 2004; Ayanoglu et al., 2010).  Extensive terminal 
protocols have not been conducted on these animals, but in a few animals that have 
been examined, airway wall remodeling and mucosal eosinophilia has been observed 
(Van Scott et al., 2004).  These characteristics are consistent with mild to moderate, 
intermittent asthma in humans that is well controlled by β-agonists and corticosteroids. 
The goal of this study was to determine if aerosol allergen exposure elicits a 
delayed, nocturnal response in house dust mite (HDM) sensitive nonhuman primates.  
Non-Allergic and dust mite sensitive animals were identified from within an existing 
colony of Cynomolgus macaques.  Correlation between RIP measurements and direct 
measures of lung resistance (RL) and dynamic compliance (Cdyn) were explored by 
inducing acute bronchoconstriction with aerosolized methacholine and house dust mite 
allergen. RIP parameters indicative of TAA exhibited a high degree of correlation with 
the conventional measures of airway function.  The animals were subsequently 
challenged with aerosolized saline or house dust mite allergen, and TAA was monitored 
by RIP for 20 hours to detect nocturnal disturbances in respiration.   
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METHODS 
Overview 
Cynomolgus macaques with documented sensitivity to aerosolized HDM for 2 or 
more years prior to the study were identified within an existing colony at East Carolina 
University.  Animals with no history of allergic sensitivity were used as Non-Allergic 
controls.  Allergic status at the time of the study was confirmed by serum levels of HDM-
specific IgE, early phase bronchoconstriction to aerosolized HDM, and late phase 
elevation of eosinophils in bronchoalveolar lavage (BAL) fluid (Table 2.1).  
Respiratory inductive plethysmography (RIP) parameters indicative of TAA were 
validated by simultaneous RIP and conventional determination of RL and Cdyn.  In an 
initial session, spontaneously breathing animals were challenged with increasing 
cumulative doses of aerosolized methacholine to induce graded changes in RL and Cdyn.  
Four weeks later, bronchoconstriction was induced with aerosolized HDM allergen, and 
then reversed by aerosolized albuterol.  Correlations between RIP parameters, RL, and 
Cdyn were then determined. 
Following the validation phase of the study, nocturnal responses to daytime 
allergen challenge were investigated.  Animals were challenged with aerosolized saline 
or HDM allergen early in the morning.  TAA was then monitored by RIP throughout the 
rest of the day and overnight.  
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Table 2.1 Characteristics for Non-Allergic and Allergic group 
Different concentrations of HDM were diluted in sterile saline. Animals were exposed to 
increasing concentrations of HDM until the concentration presented in this table elicited 
the associated changes in lung resistance (∆RL) or dynamic compliance (∆Cdyn) during 
15 minutes following the HDM challenge.   
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Serum 
α-HDM-IgE 
Eosinophils 
in BAL 
Total Cells in 
BAL 
Compartment 
HDM 
concentration ∆RL ∆Cdyn
 
(% Allergic 
Control) 
 
(%) 
 
× 106 (AU/ml) (%) (%) 
Non-Allergic 15.8 ± 3.5 1 ± 0.4 9.58 ± 3.47 2500 ± 0 0.6 ± 5.3 -5.6 ± 4.9 
Allergic 70.4 ± 5.1 35.1 ± 4.7 13.65 ± 1.76 360 ± 120.7 
103.4 ± 
16.7 -47.6 ±3.4 
P-value <0.0001 <0.0001 0.236 <0.0001 <0.0001 <0.0001 
 
Values are Mean ± SE, Non-Allergic, n = 11, Allergic, n= 21. 
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Animals 
Over a 10 year period prior to the study, thirty-eight cynomolgus macaques were 
obtained from Alpha Genesis, Inc. (Yemassee, SC) and sensitized  to HDM as 
described previously (Van Scott et al., 2004; Van Scott et al., 2005).  Briefly, animals 
were sensitized by intraperitoneal injections of Dermatophagoides pteronyssinus (Dp) 
and Dermatophagoides farinae (Df) extract adsorbed to Alum [156 units of each 
allergen (Greer Laboratories, Lenoir, NC); Imject Alum (Pierce, Rockford, IL)] at 2 to 4 
week intervals for 6 months.  Chronic airway disease was induced by subsequent 
periodic exposure to HDM aerosol at 4 to 6 week intervals.  At the time of the study, the 
animals ranged from 3.6 to 9.4 years of age, weighed 2.3 to 7.5 kg, and exhibited 
allergic asthma symptoms for 1 to 8 years.  
The animals were group housed in accordance with USDA guidelines within a 
BSL2 facility at East Carolina University, which is fully accredited by the Association for 
the Assessment and Accreditation for Laboratory Animal Care, International (AAALAC, 
Intl). All protocols were approved by the Institutional Animal Care and Use Committee of 
East Carolina University. 
Exposure to allergen between intentional provocations was minimized by HEPA 
filtration of all air circulating through the animal rooms, rinsing the rooms and cages with 
pressurized water twice each day, and running the cages through an automated washer 
weekly. All personnel entering the rooms wore appropriate personal protective gear. 
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ELISA for Allergen-Specific IgE 
Serum levels of HDM-specific IgE were measured as described previously.(Van 
Scott et al., 2004)  Ninety-six-well plates were coated with dust mite allergen (10 µg/ml 
per well, overnight at 4°C in 0.01 M sodium bicarbonate buffer, pH 9.6).  The plates 
were blocked with 10% fetal bovine serum, 100 µl of serum (1:100 dilutions) was added 
to the wells.  The plates were incubated overnight at 4°C.  IgE was detected by 
incubating with 1 µg/ml biotinylated goat anti-human IgE (Vector Lab, Burlingame, CA) 
for 1 h at room temperature, and then developing with streptavidin-conjugated 
horseradish peroxidase (BD PharMingen, San Diego, CA) and 3,3',5,5'-
tetramethylbenzidine (BD PharMingen).  The reaction was stopped by addition of 
sulfuric acid, and the absorbance at 450 nm was determined.  Relative IgE titers were 
determined by comparison to a serum sample pooled from a group of highly allergic 
animals.   
 
Determination of RL and Cdyn  
Animals were anesthetized with Telazol (2.0 mg/kg, IM), stabilized on   propofol 
(10 to 15 mg/kg/hr, IV), and intubated.  RL , Cdyn and respiratory rate (RR) were 
measured by a conventional pressure-flow technique.(Van Scott et al., 2004; Van Scott 
et al., 2005)  Tracheal airflow was measured using a heated Fleisch Pneumotachograph 
(size 00, Fleisch, Lausanne, Switzerland) connected to a Validyne pressure transducer 
(Model DP 45-14, Validyne Engineering, Northridge, CA).  Intrathoracic pressure was 
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measured using an esophageal balloon connected to a Model DP 45-24 Validyne 
pressure transducer.  Flow and pressure signals were analyzed using a MuMed PR800 
lung function recorder (MuMed, London, England).  Baselines of RL, Cdyn, and RR were 
determined during a one minute period of quiet breathing. Subsequent responses to 
aerosolized saline (vehicle), methacholine, HDM, and albuterol were expressed as raw 
data or as a percent change from baseline or saline as appropriate.  
  
House Dust Mite Challenge  
Baseline pulmonary function was recorded.  The animals were challenged for 4 
minutes with nebulized sterile saline delivered through the endotracheal tube (Devilbiss 
Ultrasonic Nebulizer, SUN-99HD, Red Lion, PA or Nouvag Ultrasonic 2000, Nouvag, 
Switzerland).  Condensation on the inner surface of the endotracheal tube was cleared 
by aspiration and pulmonary function was monitored for 1 minute.  The challenge was 
repeated with increasing concentrations of nebulized HDM allergen (1, 10, 100, 500, 
2500 AU/ml) until a 100% increase in RL or a 50% decrease in Cdyn was observed (Van 
Scott et al., 2004).  Once the target change in RL or Cdyn was observed, pulmonary 
function was monitored at 5 minute intervals for 15 minutes.  Following the last 
recording, the animals were treated with nebulized albuterol sulfate (4 minutes, 0.083% 
solution, Ventolin Nubules, Orlando, FL,). 
Arterial oxygen saturation was monitored by pulse oximetry (SurgiVet Model 
V3304, Harvard Apparatus, Holliston, MA or Cardell® Model 9403 and 9405, Sharn 
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Veterinary, inc. Tampa, FL), and supplemental O2 was delivered as needed to maintain  
O2 saturation above 70%.  
 
Methacholine Challenge  
 Animals were anesthetized and instrumented as described above.  Baseline 
pulmonary function was recorded, and sterile saline was delivered for 2 minutes.  
Condensation on the tube was cleared by aspiration, and pulmonary function was 
monitored for one minute.  Cumulative doses of methacholine (A2251, Sigma, St. Louis, 
MO)  between 0.001 mg/ml to 10 mg/ml were delivered until a 100% increase in RL 
and/or a 50% decrease in Cdyn was observed (Van Scott et al., 2004).  The range of 
aerosolized methacholine doses was based on previous experience with this model 
(Van Scott et al., 2004), published results from tissue bath experiments (Kott et al., 
2002; Joad et al., 2006), and empirical observations with this cohort of animals.  A 
methacholine concentration of 0.001 mg/ml did not induce bronchoconstriction, whereas 
concentrations greater than 10 mg/ml induced high levels of secretions in the airways.  
Therefore, 10 mg/ml methacholine was chosen as the upper level. The provocative 
concentration of methacholine leading to a 50% maximal response (PC50) for RL, Cdyn, 
and RR was calculated for individual animals, and then mean PC50 was determined for 
all animals. 
 
Endotracheal bronchoalveolar lavages 
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24 hours after HDM challenge, the animals were anesthetized with Telazol and 
propofol, and intubated.  A sterile 2.5 mm OD Tygon tube was wiped with Surgilube®, 
advanced through the endotracheal tube, and gently wedged into an airway.  The lung 
segment beyond the tip of the catheter was lavaged with 7 ml of sterile saline, which 
was collected by gentle aspiration.  Total cell counts were determined using a Coulter 
Counter (Beckman Coulter Instruments, Miami, FL).  Slides were generated using a 
Cytospin and stained with DiffQuik (VWR Scientific, So. Plainfield, NJ).  Manual 
differential cell counts were acquired by counting 200 cells per sample. 
 
Respiratory Inductive Plethysmography (RIP) 
RIP parameters were measured using the LifeShirt System (Vivometrics, Inc., 
Ventura, CA).  The LifeShirt incorporated two parallel sinusoidal wire arrays encircling 
the thorax and abdomen.  A small alternating current was passed through the wires, 
inducing a magnetic field.  Changes in the shape of the arrays during breathing altered 
the magnetic field, inducing a current that was detected as a change in the frequency of 
the applied current, which translated into lung volumes and flows on a breath by breath 
basis through coefficients obtained during calibration procedures.  Changes in animal 
posture and activity were monitored by accelerometers in the jackets allowing 
movement artifacts to be filtered out of the dataset (Prisk et al., 2002; Keenan et al., 
2005a; Keenan et al., 2005b).  
Animals were fitted with the LifeShirt jackets such that the rib cage band was 
positioned over the sternum and the abdominal band positioned immediately cephalad 
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to the pelvic girdle (Prisk et al., 2002).  The circumference of each band was adjusted to 
provide rib cage (RC) and abdomen (AB) deflections of 20 to 200 assumed milliliters 
(Aml) prior to calibration.  The LifeShirt jackets were fitted on those animals before any 
airway challenges began and were left on for about 24 hours.  Raw data records were 
analyzed with VivoLogic software (Vivometrics, Inc.).  The default settings were 
overridden to permit analysis of the small tidal volumes (100% tidal volume (Vt) = 40 
Aml; minimum acceptable Vt = 2.5%; minimum acceptable effort volume = 2.5%).  A 
Fixed Volume Calibration was then performed using the tidal volumes recorded by the 
Mumed lung function recorder during the 1 minute baseline period (Sackner et al., 1989; 
Sartene et al., 1993).  The calibrated records were used to determine the RIP 
parameters (expressed as calibrated raw data or as a percent change from baseline; 
see below) to be compared with simultaneously determined conventional measures of 
RL and Cdyn.  
Three RIP-derived parameters analyzed by the LifeShirt software were used as 
indicators of thoracoabdominal asynchrony: Phase Angle (PhAng) of the AB and RC 
waveforms, Baseline Effort Phase Relation (eBPRL), and Effort Phase Relation 
(ePhRL).  PhAng is a common parameter used to compare the initial slopes of two 
sinusoidal waveforms (Allen et al., 1990).  As abdominal and thoracic movement 
become asynchronous, PhAng increases.  Effort parameters provide an indication of the 
amount of time during a breath that deflection of the abdomen and chest wall are 
asynchronous (i.e., the two are moving in opposite directions instead of in unison).  
Baseline Effort Phase Relation (eBPRL) is the percentage of time during inspiration that 
the rib cage is moving in the opposite direction from the abdomen; and Effort Phase 
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Relation (ePhRL) is the percentage of time during the total breath that the rib cage and 
abdomen are moving in opposite directions.  Thus, thoracoabdominal asynchrony is 
associated with increases in PhAng, eBPRL, and ePhRL.  
 
Nocturnal Study 
Following HDM provocation, the animals were recovered from anesthesia and 
returned to their cages.  RIP readouts were monitored continuously until the next 
morning.  The lower threshold for movement artifact was set as the maximum 
acceleration values associated with quiet breathing for each animal while under 
anesthesia.  All records associated with accelerations greater than this maximum value 
were removed from the dataset.   
Thirty minute averages of eBPRL and ePhRL (but not PhAng: see Results) were 
plotted from 13:00 the day of HDM provocation to 6:00 the next day.  A 30 minute 
period between 13:00 and 22:00 was identified during which there was little animal 
movement and low incidence of TAA (i.e., minimum average eBPRL or ePhRL for the 
period, labeled as Baseline in Figure 2.4).  This relatively normal, quiet breathing period 
served as a baseline for the nocturnal studies.  eBPRL and ePhRL were plotted against 
time and the Area Under the Curve (AUC) between 22:00 the day of HDM challenge 
and 5:00 the next day was determined using SigmaPlot Version 10 (Systat Software, 
Inc., San Jose, CA; see Figure 2.4 for details).  The AUC was used as an indicator of 
TAA incidence and to compare nocturnal responses among subjects.  
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Statistics 
Recorded respiratory parameters were expressed as calibrated raw data or as a 
percent change from the baseline control period.  The relationships between RL, Cdyn, 
RR, and RIP parameters were investigated by simple and multiple linear regressions 
using SPSS software (SPSS, Inc., Chicago, IL).  Methacholine PC50’s of each 
parameter were determined by Hill fit analysis for each animal (Systat Software, Inc., 
San Jose, CA).  Differences between two means were assessed by Student’s t-test for 
independent observations (P≤0.05).  Differences between three or more means were 
assessed by ANOVA with Tukey HSD post-hoc test (P≤0.05). Values are reported as 
Mean ± Standard Error. 
32 
 
RESULTS 
Methacholine and HDM Challenges 
To validate RIP as a measure of TAA associated with underlying airway 
responses, the relationships between RL, Cdyn, and RIP parameters indicative of TAA 
were defined under controlled conditions where methacholine and HDM were used to 
induce acute bronchoconstriction, and albuterol to induce bronchodilation.   
Non-allergic animals had minimal changes in all parameters at the highest 
concentration of methacholine (Data not show), whereas in allergic animals the highest 
concentration of methacholine increased RR and RL and decreased Cdyn.  RR exhibited 
a higher sensitivity to methacholine than Cdyn and RL; Cdyn exhibited sensitivity to 
methacholine that was intermediate between RR and RL (Table 2.2).  These results 
were consistent with independent modulation of RR and RL, and with changes in Cdyn 
that were due to reduced alveolar filling time as RR increased.  Multiple linear 
regression of values recorded before and after methacholine challenge revealed 
significant associations of RL and Cdyn with eBPRL, ePhRL and PhAng (eBPRL: r = 
0.49, P < 0.05; ePhRL: r = 0.41, P < 0.05; PhAng: r = 0.45, P < 0.05).  
At a later date, the animals were challenged with aerosolized HDM antigen to 
induce acute bronchoconstriction, and then were treated with albuterol to reverse the 
HDM-induced bronchoconstriction.  When the effects of HDM and albuterol were 
separated, the RIP parameters tracked closely with changes in Cdyn and RL (Figure 2.1).  
Although the directions of Cdyn and RL were opposite, the relative magnitude of HDM-
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induced changes were similar (∆Cdyn: p = 0.0001 and ∆RL: p = 0.001, HDM vs. saline) 
and both parameters exhibited at least partial reversal with albuterol (Figures 2.1B and 
2.1C).  HDM provoked increases in eBPRL, ePhRL, and PhAng (p < 0.01, HDM vs. 
saline) that were reversed by albuterol (Figures 2.1D – 2.1F).  In contrast, RR increased 
with HDM (p < 0.001, HDM vs. saline), but did not reverse with albuterol (Figure 2.1A).  
These results demonstrated that TAA, as measured by changes in RIP, coincided with 
changes in RL and Cdyn induced by diverse agents. 
The aggregate HDM and albuterol data were analyzed by multiple linear 
regression, which revealed associations of RL and Cdyn with eBPRL, ePhRL, and PhAng 
as described by the following equations (See Table 2.3): 
eBPRL = 26.8 – 3.8 Cdyn + 1.7 RL  
ePhRL = 30.2 – 4.4 Cdyn + 1.7 RL    
PhAng = 98.6 – 11.4 Cdyn + 2.1 RL   
Thus, the RIP parameters increased as Cdyn decreased; and independently, after 
adjustment for Cdyn, the RIP parameters increased as RL increased.  The regression 
equations were consistent with an inverse relation between RL and Cdyn.  This 
relationship was verified by plotting coincident values of RL against Cdyn for data 
collected during both the methacholine and HDM challenges.  The resulting curve 
exhibited an inverse first order relationship (r = 0.69, P < 0.05 by simple linear 
regression of 1/RL vs. Cdyn).   
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Nocturnal Asthmatic Response to House Dust Mite Challenge 
In follow-up experiments to those discussed above, animals were challenged 
with aerosol HDM between 6:00 AM and 10:00 AM, and then acute bronchoconstriction 
was reversed with albuterol.  The animals were recovered from anesthesia, and 
returned to their cages.  Excursions of the rib cage and the abdomen were monitored 
continuously until the next morning. Figure 2.2 shows representative RIP recordings for 
one animal while anesthetized during the baseline and the early asthmatic response 
(Figure 2.2, left panels), and later while conscious during the afternoon or evening 
baseline and the nocturnal asthmatic response (Figure 2.2, right panels).  PhAng 
(calculated from the Konno-Mead diagram) has been used in previous studies to assess 
TAA (Allen et al., 1990; Rusconi et al., 1995; Prisk et al., 2002), however, PhAng is 
affected by the shape of the abdominal and ribcage waveforms, with a triangular 
waveform being associated with increased error (Rusconi et al., 1995; Prisk et al., 
2002).  Triangular waveforms were commonly observed in the current study (Figure 
2.2), and therefore, PhAng was not used as an indicator of TAA at night.  The effort 
parameters, eBPRL and ePhRL, correlated well with labored breathing exhibited during 
the acute response to HDM and methacholine provocation, and were therefore used to 
monitor for nocturnal respiratory disturbances.    
To assess the long-term stability of eBPRL and ePhRL, both parameters were 
recorded in Non-Allergic animals overnight.  No significant change was observed in 
eBPRL and ePhRL over the nocturnal time period between 22:00 and 5:00 (Figure 2.3), 
whereas in most Allergic animals eBPRL and ePhRL gradually increased from the 
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baseline, reaching a peak value around 3:30 (Figure 2.4).  To quantify nocturnal TAA, 
we determined the Area Under the Curve (AUC) between 22:00 and 5:00 and 
determined the 99% confidence intervals for Non-Allergic animals (dashed line in Figure 
2.5A and B).  Plots of eBPRL and ePhRL against time for Allergic animals revealed 15 
of 21 animals with AUCs greater than the upper boundary of the 99% confidence 
interval; these 15 animals were therefore classified as nocturnal asthmatic responders 
(NAR).  The Allergic group mean AUCs for changes in eBPRL and ePhRL were greater 
than Non-Allergic control group mean AUCs (Figure 5A and B, ∆eBPRL: p < 0.001, 
∆ePhRL: p = 0.001).  In control experiments, the NAR group did not exhibit nocturnal 
responses following challenges between 6:00 AM and 10:00 AM with aerosolized saline 
alone (data not shown).  
To evaluate the reproducibility of the nocturnal response, eight animals exhibiting 
acute responses to HDM were rechallenged at a later date (Figure 2.6).  Six of the 
animals had been classified as NARs in the previous trial (shown as six symbols above 
the dashed lines for challenge number 1, Figure 2.6) and two animals had not been 
classified as NARs.  Four of these six NARs from the first trial exhibited nocturnal 
responses following the second challenge (Figure 2.6).  Both the animals that had not 
been classified as NARs in the previous trial exhibited nocturnal responses for 
challenge number 2. Conversely, two animals that exhibited a nocturnal response 
following the first challenge exhibited minimal increase in eBPRL and ePhRL following 
the second challenge.  Manifestation of a nocturnal response and its magnitude could 
not be attributed to the provocative concentration of HDM used to elicit the early phase 
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response or the magnitude of the change in RL and Cdyn during early phase response 
(data not shown).  
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Table 2.2 Methacholine PC50’s of conventional respiratory indexes  
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Methacholine PC50  
(mg/ml) ANOVA (P value) 
Mean SE RR Cdyn RL 
RR 0.07 0.01 -- 0.031 0.001 
Cdyn 0.23 0.05 0.031 -- 0.001 
RL 0.63 0.09 0.001 0.001 -- 
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Figure 2.1 Responses to sequential exposure of aerosolized saline, the maximum 
concentration of house dust mite extract (HDM) and albuterol 
Shown are changes in (A) respiratory rate (RR), (B) dynamic compliance (Cdyn,), (C) 
lung resistance (RL), (D) Baseline Effort Phase Relation (eBPRL), (E) Effort Phase 
Relation (ePhRL), and (F) Phase Angle (PhAng). Responses to saline and HDM were 
recorded in 23 animals. Albuterol was administered to 8 animals exhibiting severe and 
prolonged increases in airway resistance. The changes were expressed as a 
percentage of the baseline measurement recorded prior to saline delivery. Values are 
means ± SE. 
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Table 2.3 Multiple linear regression results of eBPRL, ePhRL, and PhAng 
recorded during the first 30 minutes following a HDM challenge 
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Dependent 
variable 
Independent 
variable 
Regression Coefficients 
tbj P bj 
Std. Error 
sbj 
eBPRL 
Intercept 26.80 13.72 1.95 0.056 
Cdyn -3.85 1.25 -3.08 0.003 
RL 1.65 .41 4.08 <0.001 
ePhRL 
Intercept 30.15 13.99 2.16 0.035 
Cdyn -4.43 1.27 -3.48 0.001 
RL 1.68 .41 4.06 <0.001 
PhAng 
Intercept 98.62 25.20 3.91 <0.001 
Cdyn -11.42 2.29 -4.98 <0.001 
RL 2.07 .74 2.782 0.007 
 
The p-value is a test of H0: βj = 0 against Ha: βj ≠ 0 
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Figure 2.2 Representative RIP recordings of one animal (ID: 8065) during both the 
early asthmatic response (EAR) and the nocturnal asthmatic response (NAR) 
Excursions of the rib cage (RC) and the abdomen (AB), as well as corresponding 
eBPRL, ePhRL, and PhAng are shown for multiple breaths. Note the triangular RC and 
AB wave forms, and that eBPRL and ePhRL are better reflections of TAA than PhAng 
during the EAR peak and also are good reflections of TAA during NAR peak. The 
Konno-Mead diagram (bottom of each vertical panel) shows the direction of RC 
movement (dRC) and the direction of AB movement (dAB) during inhalation and 
exhalation in three breaths.   
44 
 
2 4 6 8 2 4 6 8 2 4 6 8 2 4 6 8
Baseline EAR Peak
30
RC (ml)  15
0
30
AB (ml)  15
0
100
eBPRL (%)   50
0
100
ePhRL (%)   50
0
180
PhAng (deg) 90
0
Baseline (NAR) NAR Peak
20
RC (ml)  10
0
20
AB (ml)  10
0
100
eBPRL (%)   50
0
100
ePhRL (%)   50
0
180
PhAng (deg) 90
0
dRC
dAB dAB
dRC
dAB dAB
Time (sec) Time (sec) Time (sec) Time (sec)
 
45 
 
 
Figure 2.3 Long-term stability of nocturnal eBPRL and ePhRL 
Plots of eBPRL and ePhRL (30 minute averages) starting at 22:00 and ending at 5:00 
AM next morning in 11 Non-Allergic animals. The changes were expressed as a 
percentage of the baseline measurement recorded during afternoon.  Values are means 
± SE at each time point. 
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Figure 2.4 Representative nocturnal eBPRL and ePhRL response of the same 
animal represented in figure 2 (ID: 8065) 
Plot of eBPRL (filled circle) and ePhRL (open circle) (30 minute averages) starting at 
13:00 and ending at 6:00 AM next morning. Area under the curve (AUC) was started at 
22:00 and ended at 5:00 AM.  
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Figure 2.5 Changes in eBPRL (A) and ePhRL (B) between 22:00 and 5:00 for each 
individual animal in both the Allergic group (n=21) and the Non-Allergic group 
(n=11)  
(A and B) The Allergic group mean AUCs for eBPRL and ePhRL were significantly 
greater than Non-Allergic control group mean AUCs.  The arrow indicates values for 
animal ID: 8065 that is also represented in Figure 2 and 4. Dashed lines represent the 
upper bound of the 99% confidence interval for the Non-Allergic group. 
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Figure 2.6 Reproducibility of the nocturnal response to house dust mite challenge 
Eight animals were challenged with HDM on two different dates. AUC for eBPRL (A) 
and ePhRL (B) are shown.  Symbols represent individual animals. Dash lines represent 
the upper bound of the 99% confidence intervals for the Non-Allergic group. The 
symbols above the dashed lines were classified as nocturnal asthmatic responders 
(NARs).  
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DISCUSSION 
In spontaneously breathing animals, large and small airway constriction manifest 
as changes in resistance and compliance.  These changes may contribute to 
thoracoabdominal asynchrony (TAA) which results from inability of thoracic volume to 
change in phase with abdominal volume due to restricted airflow through the lungs.  To 
our knowledge, this is the first report on the use of RIP to measure TAA in a nonhuman 
primate model of allergic asthma and to apply the technique to document nocturnal 
responses in an animal model of asthma.  TAA as indicated by RIP Effort Phase 
Relation parameters correlated with changes in Cdyn and RL in Cynomolgus macaques 
during bronchoconstriction induced by methacholine or HDM, and bronchodilation 
induced by albuterol.  Following HDM challenge in the early morning, TAA was shown 
to increase with a peak between 3:00 and 4:00 the next morning.  The nocturnal 
response exhibited intra-animal variability in both incidence and magnitude, which is 
consistent with manifestation of nocturnal asthma symptoms in humans. 
RIP has been used extensively to assess apnea and breathing patterns during 
sleep in humans (Whyte et al., 1991; Cantineau et al., 1992; Kaplan et al., 2000; 
Kohyama et al., 2001; Brown et al., 2008b) and animals (Warren et al., 1989).  Multiple 
human studies have demonstrated correlations among TAA, bronchoconstriction, and 
bronchodilation (Allen et al., 1990; Rusconi et al., 1995; Springer et al., 1996).  In 
contrast to TAA, other RIP parameters, particularly ventilation, do not appear to be 
useful in assessing pulmonary function in asthmatic subjects (Stromberg et al., 1996b; 
Black et al., 2004), possibly due to artifact induced in volume measurements by 
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asynchronous movement of the chest wall and abdomen during 
bronchoconstriction.(Fujimori et al., 1996)  In this study of allergic nonhuman primates, 
TAA as measured by RIP correlated with changes in RL and Cdyn during HDM- and 
methacholine-induced bronchoconstriction.  In contrast, a previous study in foals did not 
observe these correlations during histamine-induced bronchoconstriction (Miller et al., 
2000).  The reason for this discrepancy is not clear.   
In asthmatics there is a high prevalence of nocturnal symptoms (Ballard et al., 
1989; Irvin et al., 2000) with peak pulmonary resistance (Irvin et al., 2000) and airway 
inflammation (Kraft et al., 1999b; Kelly et al., 2004) observed around 4:00 AM.  In this 
study of allergic nonhuman primates, both eBPRL and ePhRL gradually increase during 
the night following an early morning HDM challenge, which is consistent with the time 
course of nocturnal symptoms in humans.  These nocturnal increases in TAA may be 
linked to underlying bronchoconstriction, but this cannot be proven without overt 
intervention at night.  TAA is also impacted by changes in respiratory muscle load, 
control of auxiliary muscle of breathing, and respiratory muscle dysfunction (Hammer et 
al., 2009).  These factors cannot be excluded as underlying causes of nocturnal TAA.  
Regardless, the data provide compelling evidence that daytime exposure to allergen 
results in nocturnal disturbances in breathing.    
The incidence and severity of nocturnal asthma symptoms in humans is variable, 
both between and within subjects (Turner-Warwick, 1988; Storms et al., 1994).  
Likewise, nocturnal TAA following HDM challenge in allergic nonhuman primates was 
variable between animals and within individual animals over time.  Shigemitsu and 
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colleagues (Shigemitsu et al., 2007) reported that 60% of asthmatic subjects manifest 
nocturnal symptoms.  This number compares favorably with the 71% incidence 
observed in the current study.  Fix et al. reported that occurrence of nocturnal 
symptoms is linked to the severity of asthma (Fix et al., 1997), but other investigators 
failed to substantiate a definitive link between any particular phenotypic feature of early 
acute allergic responses and late asthmatic responses in humans and animals 
(Robertson et al., 1974; O'Byrne et al., 1987; Nabe et al., 2005), including the 
occurrence of nocturnal symptoms (Turner-Warwick, 1988).  In the NHP model, 
nocturnal TAA could not be attributed to any of the functional parameters measured 
during the early asthmatic response, including the provocative concentration of HDM or 
the magnitude of the acute bronchoconstriction.  
In summary, RIP parameters indicative of TAA correlated with decrease in 
pulmonary function during methacholine challenge and the early asthmatic response in 
HDM-sensitive Cynomolgus macaques.  Using RIP as a measure of TAA revealed 
nocturnal changes in pulmonary function following daytime exposure to aeroallergen.  
While increased TAA is consistent with bronchoconstriction, the changes may not be 
due solely to changes in RL and Cdyn.  Regardless, the results provide compelling 
evidence that daytime exposure to aeroallergen in allergic nonhuman primates is 
associated with increased incidence of nocturnal disturbances in breathing.  Taken 
together, the results indicate that symptoms of nocturnal asthma can be induced in 
nonhuman primates, providing a model for elucidating the mechanisms underlying 
circadian manifestation of asthma symptoms.   
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CHAPTER 3:  A CIRCADIAN CLOCK IN MURINE BONE MARROW-DERIVED MAST 
CELLS (BMMCs) MODULATES IgE-DEPENDENT ACTIVATION in vitro 
 
JOURNAL SUBMISSION PENDING 
 
SUMMARY 
 Circadian rhythm is expressed in most organisms, and many functions and 
parameters in the immune system are associated with time-of-day. For instance, blood 
histamine levels in patients with mastocytosis display a diurnal variation. In addition, 
pulmonary function and inflammation in patients with nocturnal asthma is more severe 
during the night than the daytime. However, it is largely unknown if local circadian 
clocks in immune cells directly control physiological outcomes. We hypothesized that a 
circadian clock in murine bone marrow derived mast cells (BMMCs) modulates IgE-
dependent activation in vitro. 
 Mature BMMCs, grown from bone marrow of C57BL/6 mice, were synchronized 
with serum rich media (50% horse serum). Total RNA was harvested from BMMCs at 4 
hour intervals for up to 72 hours following synchronization and expression of circadian 
genes (mPer1, mPer2, Bmal1, Rev-erbα, and Dbp) and IgE receptor gene (fcer1a) were 
amplified by quantitative PCR. The surface expression of FcεRIα was analyzed by flow 
cytometry every 4 hours for up to 72 hours following synchronization. Synchronized 
BMMCs were activated by IgE/Antigen or ionomycin at given time points. Total RNA of 
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cytokines was harvested 30 minutes after BMMCs activation and was amplified by 
quantitative PCR. Cytokines were collected from supernatant 4 hours after BMMCs 
activation and were analyzed by ELISA.   
 Serum shock synchronized rhythmic expressions of circadian genes (mPer2, 
Bmal1, Rev-erbα, and Dbp) in BMMCs. Synchronized BMMCs stimulated with IgE/Ag at 
different circadian times displayed circadian rhythms in IL-13 mRNA.  The expression of 
fcer1a gene and FcεRIα protein displayed a circadian pattern following serum shock, 
with mean periods of 18.9 and 28.6 hours respectively. These results demonstrate that 
synchronized BMMCs provide an in vitro model to study circadian mechanism 
associated with allergic disease and that circadian oscillation of FcεRIα may contribute 
to the circadian oscillation of cytokine production following IgE-dependent activation. 
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INTRODUCTION 
Circadian rhythm is a conserved feature of organisms ranging from 
cyanobacteria to humans (Dunlap, 1999) that is manifest as oscillations of biological 
processes with a periodicity of approximately 24 hours.  The circadian system consists 
of three components: sensors, pacemakers, and effectors.  Sensors include both photic 
and non-photic receptors that entrain the central clock to environmental cues.  Afferent 
pathways convey information from the sensors to pacemakers that establish the rhythm, 
and efferent pathways alter effector organ function according to the established rhythm.  
In mammals, a central circadian pacemaker located in the suprachiasmatic nucleus 
(SCN) of the ventral hypothalamus (Gekakis et al., 1998) coordinates oscillators in 
peripheral organs (Reppert et al., 2002).   
The core circadian molecular clock in mammals consists of a series of 
transcriptional and translational loops involving Period1-3, Clock, Bmal1, and Cry1-2 
genes (Takahashi et al., 2008).  CLOCK and BMAL1 heterodimers translocate into the 
nucleus, binding to E-box motifs (CACGTG), and activating transcription of Per and Cry 
genes (Gekakis et al., 1998).  PER and CRY proteins synthesized in the cytoplasm 
accumulate to a critical level, and bind to CKIε/δ kinase.  The phosphorylated 
heterotrimers  translocate into the nucleus, and inhibits CLOCK-BMAL1 heterodimers, 
thereby inhibiting transcription of their own genes and other clock controlled genes 
(CCGs) (Kume et al., 1999).  Another feedback loop directs alternating activation and 
repression of BMAL1 expression by the nuclear receptors RORα and REV-
ERBα (Etchegaray et al., 2003), respectively(Sato et al., 2004; Emery et al., 2004). 
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Circadian oscillations in individual cells that are not entrained to an external 
signal is uncoordinated, and therefore self-sustained oscillation in populations of cells is 
unsynchronized. Detuned circadian oscillators observed in cell lines (Nagoshi et al., 
2004) and some primary cells (Keller et al., 2009) can be synchronized by a serum 
shock (Balsalobre et al., 1998; Nagoshi et al., 2004; Durgan et al., 2005) or 
pharmacological substances (Balsalobre et al., 2000a; Wu et al., 2007; Wu et al., 2008; 
Huang et al., 2009; Yagita et al., 2010).   
Many diseases, including allergic asthma, exhibit circadian variation of 
symptoms. Nocturnal symptoms of asthma are common and include 
bronchoconstriction, airway inflammation and hyperreactivity, dyspnea, cough, and 
apnea during the night (Ballard et al., 1989; Kraft et al., 1999b; Irvin et al., 2000; Kelly et 
al., 2004; Smolensky et al., 2007).  Mast cells play a central role in allergic diseases 
(Brown et al., 2008a); and circadian rhythmicity is an established feature of many 
immune cells, including peripheral blood mononuclear cells (PBMCs) Born et al1997.,) 
(Murphy et al., 2007), natural killer (NK) cells (Arjona et al., 2006), and peritoneal 
macrophages(Keller et al., 2009).  While it remains unknown how circadian variation 
may directly influence mast cell function, it has been reported that plasma histamine 
levels in patients with mastocytosis exhibit a circadian variation (Friedman et al., 1989), 
and circadian variation in mast cell number has been observed in thyroid gland(Catini et 
al., 1994), ovaries, (Gaytan et al., 1991), tongue, pinna and dorsal skin(Chen et al., 
1989). Despite this evidence, it remains unknown whether circadian clock genes are 
expressed in the mast cells and whether these genes influence mast cell function.  
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 Crosslinking of FcεRI (high-affinity IgE receptor) on the surface of mast cells by 
Ag/IgE results in immediate release of preformed inflammatory mediators including 
histamine and proteases, that initiate an immediate hypersensitivity reaction (Metcalfe 
et al., 2009).  In addition, activation of mast cells stimulates production of cytokines and 
chemokines, including IL-6, IL-13, CXCL8 and CCL3, which promote the late-phase 
inflammatory reactions.   
The present study was conducted to test the hypothesis that a circadian clock 
expressed in murine bone marrow derived mast cells (BMMCs) modulates IgE-
dependent activation in vitro.  BMMCs were serum shocked with a high concentration of 
horse serum, and expression of circadian clock genes (mPer1, mPer2, Bmal1, Rev-
erbα, and Dbp) were monitored for up to 72 hours.  Inflammatory cytokines were 
measured following FcεRI stimulation to examine the influence of circadian rhythm on 
mast cell activation.  Lastly, rhythmic expression of FcεRI, the high affinity IgE receptor, 
was evaluated by both quantitative real-time PCR and flow cytometry. 
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METHODS 
Animals 
 Four week-old C57BL/6 mice were obtained from The Jackson Laboratories (Bar 
Harbor, ME).  Mice were euthanized by CO2 asphyxiation followed by collection of 
femoral bone marrow for generation of BMMCs.  All animal protocols were approved by 
the Institutional Animal Care and Use Committee of East Carolina University.  
 
Cell Culture 
Mouse BMMCs were cultured from femoral bone marrow of C57BL/6 mice.  Bone 
marrow was collected from 3-4 mice per BMMC culture and all experiments were 
repeated 6 times, each with different culture of BMMCs.  Cells were cultured in RPMI 
1640 supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 25 mM 
HEPES, 1 mM sodium pyruvate, nonessential amino acids (Sigma-Aldrich, St. Louis, 
MO), 0.0035% 2-mercaptoethanol, and 300 ng/ml recombinant murine IL-3 (PeproTech, 
Rocky Hill, NJ).  BMMCs were used after 4-6 weeks of culture, a time at which >95% of 
the cells are mast cells as determined by granule content and high expression of FcεRI.  
 
Synchronization of BMMC by Serum Shock 
Bone marrow-derived mast cells were plated in 25 cm2 cell culture flask.  At time 
t = 0, the medium was exchanged with serum rich medium (RPMI 1640 supplemented 
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with 50% horse serum (GIBCO), 100 U/ml penicillin, 100 µg/ml streptomycin, 25 mM 
HEPES, 1 mM sodium pyruvate, nonessential amino acids, 0.0035% 2-
mercaptoethanol, and 300 ng/ml recombinant murine IL-3), and after 2 hours this 
medium was replaced with 1% FBS RPMI with IL-3 (Balsalobre et al., 1998).  At the 
time points indicated in Figure 3.1A, BMMCs were collected for subsequent analysis as 
described below.   
 
Quantitative Real-Time PCR 
Total RNA from BMMCs was isolated at 4 hour intervals after serum shock using 
a Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA).  RNA was reverse transcribed to 
obtain cDNA using a QuantiTect reverse transcription kit (Qiagen).  Quantitative real-
time PCR was performed using QuantiTect primer assays and SYBR green master mix 
(Qiagen).  A Bio-Rad iCycler was used to obtain cycle threshold (Ct) values for target 
and internal reference cDNA levels. Target cDNA levels were normalized to GAPDH, an 
internal reference using the equation 2-[∆Ct], where ∆Ct is defined as Cttarget – Ctinternal 
reference.  Values shown are the average of 6 independent experiments conducted with 6 
different batches of BMMCs. 
 
FcεRI-mediated BMMC activation 
Mouse BMMCs were seeded at 1×106 cells/well in a 6-well plate and sensitized 1 
hour with 1 µg/ml mouse IgE anti-DNP (Sigma-Aldrich) at each given time point 
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following serum shock. Following 1 hour sensitization, cells were washed with PBS and 
100 ng/ml DNP-HSA was added to the cells (Sigma-Aldrich) (see Figure 3.1B for time 
course). Total RNA from BMMCs was isolated 30 min following addition of DNP using a 
Qiagen RNeasy Mini Kit.  Supernatants of BMMCs that had been incubated with IgE 
and stimulated with DNP for 4 hours were analyzed for IL-6, IL-13, MIP-1α and TNF-α 
using a mouse Duo-Set ELISA system (R&D Systems, Minneapolis, MN).   
In addition to FcεRI-mediated activation, BMMCs were seeded at 1×106 cells/well 
and stimulated with 0.5 µm ionomycin (Sigma-Aldrich) at each given time point following 
serum shock (Figure 3.1B).  Total RNA and supernatants from BMMC cultures were 
collected respectively at 30 min and 4 hours after incubation with ionomycin as 
described above.  
 
Flow Cytometry 
For measurement of FcεR1α, BMMCs were harvested at indicated time points 
after serum shock and incubated with 2 µg/ml phycoerythrin (PE)-conjugated anti-
mouse FcεR1α (MAR-1, eBioscience) at room temperature for 30 min. PE-labeled 
Armenian Hamster IgG (eBioscience) was used as isotype control. Flow cytometric 
analysis of the stained cells was performed with a FACScan flow cytometer (Becton, 
Dickinson and Company) equipped with CELLQUEST software. 10,000 BMMCs per 
sample were analyzed and mean fluorescence intensity (MFI) values at each time point 
are reported.   
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Periodicity Analysis 
The time series data of circadian gene expression, fcer1a gene expression, and 
FcεR1α mean fluorescence intensity (MFI) were analyzed for circadian rhythmicity by 
the cosinor method (Nelson et al., 1979; Bingham et al., 1982). The time series of the 
parameters of the cosinor, i.e. amplitude (half the difference between the minimum and 
maximum of the fitted cosine function), MESOR (middle value of the fitted cosine curve 
representing the rhythm adjusted mean) and acrophase (time of peak value of the fitted 
cosine function), were tested by the cosinor parameters test designed by Bingham et al 
(Bingham et al., 1982). 
 
Statistical Analysis 
  Variation in cytokine expression and circadian gene expression in activated BMMC 
data were analyzed by one-way ANOVA or two-way ANOVA using SPSS software 
(SPSS, Inc., Chicago, IL) followed by Bonferroni post hoc tests where appropriate.  
Values are reported as Mean ± Standard Error.  A value of p < 0.05 was considered 
significant.  
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Figure 3.1 Protocols 
Serum shock synchronization protocol (A) and IgE/Ag or ionomycin stimulation protocol 
(B).  Samples were collected at each time point indicated. 
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RESULTS 
Expression of Circadian Clock Genes in Serum Synchronized BMMCs  
Following a 2 hour synchronization with serum rich media (50% horse serum), 
expression of mPer2, Bmal1, Rev-erbα, and Dbp exhibited a robust oscillation over a 72 
hour period (Figure 3.2). mPer2 and Rev-erbα, which are negative regulatory arms of 
the circadian transcriptional complex, displayed peak expression levels at 19.8 and 18.5 
hours following synchronization. In contrast, Bmal1, a positive regulatory arm of the 
circadian transcriptional complex, exhibited peak phase at 5.9 hours after 
synchronization (Table 3.1).  The peak expression of Bmal1 was 14 hours in advance of 
the peak phase of mPer2.  Overall, serum shock synchronized an oscillating expression 
profile of circadian gene mRNAs as a function of time in BMMC. 
 
Cytokine Production in Serum Synchronized BMMCs following IgE-Dependent 
and IgE–Independent Activation  
Since we demonstrated circadian clock genes are rhythmically expressed in 
BMMC, we next determined if they influence activation of BMMCs.  To address this 
question, cytokine mRNA expression profiles were investigated following either IgE 
sensitization and Ag challenge or ionomycin stimulation in synchronized BMMCs at the 
indicated time points (0 hour, 8 hour, 24 hour, 40 hour, 56 hour, and 64 hour).  IL-13 
mRNA expression levels peaked at 0 and 56 hours following FcεRI stimulation, while 
expression was lowest at 8 hours (p < 0.05, Figure 3.3A).  Interestingly, IL-6 mRNA 
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expression levels displayed the same pattern following IgE/Ag stimulation as IL-13 
mRNA expression following serum shock (Figure 3.3B).  However, the peak and nadir 
of IL-6 mRNA expression levels in FcεRI stimulated BMMCs did not reach statistical 
significance.  In synchronized BMMCs, ionomycin stimulated IL-13 mRNA production 
did not display any circadian oscillation (Figure 3.3C).  Likewise, IL-6 mRNA expression 
levels in ionomycin treated synchronized BMMCs displayed no oscillation over 72h 
(Figure 3.3D).  In synchronized BMMCs, TNFα and MIP1α mRNA expression following 
activation by IgE/Ag or ionomycin did not result in circadian oscillation (data not shown).  
In contrast to mRNA expression levels, IL-13 (Figure 3.4 A and C), IL-6 (Figure 
3.4 B and D), TNFα  (data not shown), and MIP1α  (data not shown) protein secretion 
from FcεRI or ionomycin stimulated synchronized BMMCs did not display any circadian 
oscillation. 
 
Effects of FcεRI-mediated BMMC Activation on mPer2 Expression  
To test whether FcεRI stimulation influences the oscillating expression of the 
circadian gene mPer2, mRNA expression profiles were investigated in 3 treatment 
groups: serum shocked BMMCs, FcεRI activated BMMCs synchronized by serum 
shock, and FcεRI activated BMMCs in the absence of serum shock.  FcεRI stimulation 
had little effect on mPer2 expression over 72 hours in unsynchronized cells (Figure 3.5). 
Serum shock alone, induced/unmasked a circadian oscillation in mPer2 levels 
(F(5,90)=3.760, p=0.004).  However, FcεRI activation in combination with serum shock 
69 
 
did not affect the amplitude or phase of mPer2 mRNA oscillation.  A significant effect of 
three groups on mPer2 levels were observed (F(2,90)=4.197, p=0.018). 
 
Circadian Expression of FcεRIα in Serum Synchronized BMMCs 
To test if FcεRIα expression is under circadian control in mast cells, FcεR1α 
mRNA levels were determined by quantitative real-time PCR in BMMC every 4 hours up 
to 72 hours following synchronization. FcεR1α mRNA expression displayed a circadian 
oscillation, with a robust peak at 12 hours and a depression around 22 hours following 
synchronization (Figure 3.6).  Further, this circadian oscillation of FcεR1α mRNA levels 
was maintained up to 72 hours following synchronization. 
To investigate whether FcεRIα protein is expressed in a circadian pattern, we 
measured surface expression of FcεRI by flow cytometry every 4 hours following 
synchronization.  Figure 3.7A shows the surface expression profiles of FcεRI at 
representative time points following synchronization of BMMCs.  FcεRIα expression at 
32 hours displayed a left shift as compared to 8 hours or 64 hours indicating that 
receptor expression at 32 hours is higher than the other 2 time points.  Mean 
fluorescence intensity (MFI) of FcεRIα expression showed a circadian oscillation, with a 
robust peak at 28 hours following synchronization (Figure 3.7).  The rhythm in FcεRIα 
surface expression levels was out of phase with mRNA levels (Figure 3.6 and Figure 
3.7B).  Without synchronization, MFI values of FcεRIα expression on BMMCs did not 
show any oscillation over 72 hours (data not shown).   
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Figure 3.2 Circadian clock gene expression in BMMCs following serum shock.  
mRNA expression of circadian clock genes (A) mPer2, (B) Bmal1, (C) Reverba, and (D) 
Dbp.  mRNA expression was normalized to non-oscillating gapdh expression levels and 
expressed as a percentage of mRNA expression in non-serum shocked cells.  Gray 
lines represent mean ± S.E.M. for expression data. The blue line displays best-fitting 24 
hour cosine analysis predicted by Time Series Analysis-Single Cosinor v. 6.3 software. 
n = 6 independent experiments. 
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Table 3.1 Peak Phases and Amplitudes of Circadian Clock Gene Expression in 
BMMCs  
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Circadian Gene  Peak-phase (h)  Amplitude*  P value 
¶
  
Bmal1  5.93 85.30 0.0098 
Dbp  17.27 48.00 0.0002 
Rev-erbα  18.53 206.00 0.0001 
mPer2  19.8 33.1 0.0056 
 
*Amplitudes and ¶P values (H0: Amplitude=0) have been calculated by Time Series 
Analysis-Single Cosinor v. 6.3 software (Expert Soft Technologie). n = 6 independent 
experiments 
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Figure 3.3 Cytokine mRNA expression in synchronized BMMCs following IgE-
dependent and –independent activation.   
BMMCs, following serum shock, were sensitized with IgE anti-DNP and stimulated for 
30 min with (A & C) DNP or (B & D) ionomycin, and cells were collected. (A & B) IL-13 
and (C & D) IL-6 mRNA expression following activation were normalized to non-
oscillating Gapdh expression levels and expressed as a percentage of the non-serum 
shocked controls. Data is presented as mean ± S.E.M. n = 6 independent experiments. 
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Figure 3.4 Cytokine expression in synchronized BMMCs following IgE-dependent 
and –independent activation.   
BMMCs, following serum shock, were sensitized with IgE anti-DNP and stimulated for 4 
hours with (A & C) DNP or (B & D) ionomycin, and supernatant were collected. (A & B) 
IL-13 and (C & D) IL-6 expression following activation were normalized to non-
oscillating Gapdh expression levels and expressed as a percentage of the non-serum 
shocked controls. Data is presented as mean ± S.E.M. n = 3 independent experiments. 
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Figure 3.5 Effect of FcεRIα-dependent activation on circadian gene expression.  
BMMCs were treated with serum, IgE+DNP, or both.  Serum shock alone (solid line), 
IgE +DNP alone (dash line), serum shock in combination with IgE+DNP (dot line). 
mPer2 expression were determined by quantitative real-time PCR, normalized to non-
oscillating Gapdh, and  expressed as percentage of 0 hour without serum shock.  Data 
is presented as means ± S.E.M. n = 6 independent experiments.  *: p <0.05 IgE+DNP 
vs50% HS or 50% HS + IgE/DNP 
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Figure 3.6 FcεRIα mRNA expression in BMMCs following synchronization.  
mRNA levels of fcer1a in BMMCs following serum shock (mean ± S.E.M., n = 6, best-
fitting cosine blue line).  
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Figure 3.7 FcεRIα expression in BMMCs following synchronization. 
(A) Surface protein expression of FcεRIα in BMMCs following serum shock. Histogram 
on the left shows 3 representative time points (8h, 32h, and 64h). (B) Mean 
fluorescence intensity (MFI) values are shown as mean ± S.E.M. (gray line) at each 
time point with best-fitting cosine blue line (n=3).  
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DISCUSSION 
The most important finding in this study is that circadian clock genes are 
rhythmically expressed in serum synchronized mouse bone marrow-derived mast cells.  
Cytokine mRNA expression following IgE-dependent activation of BMMCs and serum 
synchronization exhibited a trend towards a circadian pattern.  However, IgE/Ag 
stimulation of BMMCs did not shift existing circadian expression of a key circadian 
gene, mPer2.  Following serum synchronization, the expression of FcεRIα displayed a 
circadian pattern that was associated with changes in cytokine mRNA expression in 
activated BMMCs.   
Circadian clock genes are expressed in a number of immune cells including 
natural killer (NK) cells (Arjona et al., 2005; Arjona et al., 2006; Arjona et al., 2008), 
macrophages (Keller et al., 2009), and T-cell subsets (Dimitrov et al., 2009).  In this 
study, we provide the first evidence that circadian clock genes are expressed in BMMCs 
in a circadian pattern for up to 72 hours following serum shock. Serum shock is a 
common method utilized to synchronize the circadian clock in cell cultures and is 
equivalent to the ability of light cycles to entrain the circadian clock in vivo(Hastings et 
al., 2003). It does not jumpstart damped circadian oscillators but instead synchronizes 
dephased circadian oscillators.  This has been demonstrated in fibroblasts,  where 
individual cells have been found capable of generating self-sustained circadian rhythms 
of gene expression (Balsalobre et al., 1998; Nagoshi et al., 2004). Here we report that 
serum shock synchronizes individual rhythms in BMMCs to a common phase as does it 
in fibroblasts (Balsalobre et al., 1998; Nagoshi et al., 2004), adipose-derived stem cells 
(Wu et al., 2007), natural killer cells (Murphy et al., 2007), and cardiomyocytes (Durgan 
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et al., 2005).  The mechanism(s) underlying serum shock synchronization of circadian 
gene expression in vitro is still unknown. Neither the activation of cAMP-dependent 
kinases nor the glucocorticoid receptor appear to be required for the synchronization of 
circadian gene expression by serum shock (Balsalobre et al., 2000b).  
The phase relationship between rhythms of circadian genes in BMMCs is 
consistent with that in other cells.  The heterodimer Bmal1 and Clock binding to E-box in 
the promoter region of other circadian genes to initiate their expression parallels with 
other cell types. In BMMCs, the expression of Bmal1 occurs earlier than Rev-erbα and 
mPer2.  Further, the increased expression of Rev-erbα correlates with decreased 
expression of Bmal1. Lastly, the expression of mPer2 appears to inhibit the formation of 
the heterodimer BMAL1 and CLOCK. Taken together, these results indicate that mast 
cells contain a local intrinsic clock.  
The function of a local intrinsic clock in BMMCs was investigated by measuring 
the activation of cells at specific time points following serum shock synchronization.  
Several studies have shown a circadian variation of cytokine levels in NK cells and 
macrophages (Arjona et al., 2005; Hayashi et al., 2007; Keller et al., 2009).  TNF-α and 
IL-6 secretion patterns exhibit a circadian oscillation in ex vivo LPS-stimulated 
macrophages (Keller et al., 2009). Here, we report rhythms in mRNA levels of IL-13 and 
IL-6 in IgE-mediated activation of synchronized BMMCs.  Mast cells, activated through 
antigen- and IgE-dependent aggregation of the high affinity IgE receptor, FcεRI, 
produce a broad range of mediators, including preformed mediators and newly 
synthesized cytokines/chemokines (Galli et al., 2008; Kalesnikoff et al., 2008; Brown et 
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al., 2008a). Newly synthesized cytokines produced by mast cells include, but are not 
limited to, IL-6, IL-13, and TNF-α.  We tested IL-13 production over time due to the 
important role of IL-13 in allergic asthma by initiation of a late phase response(Toru et 
al., 1998), induction of IgE synthesis by B cells(Punnonen et al., 1994), proliferation of 
mast cells, and increasing FcεRI expression(Kaur et al., 2006). The phases of IL-13 
mRNA were oscillated with nadirs at 8 hours and 40 hours and peaks at 24 hours and 
56 hours. These observations suggest mast cells stimulated by IgE/Ag along the 
circadian cycle could possibly have different outcomes.  The oscillation of cytokine 
mRNA produced by IgE-dependent activation of mast cells may be associated with 
circadian pathological responses that have been observed in patients with 
mastocytosis(Catini et al., 1994) and nocturnal responses in allergic asthma 
(Smolensky et al., 2007).  
Other than activation through FcεRI, mast cells can also participate in 
physiological and pathological processes as a result of their activation by certain 
chemicals. To verify whether circadian oscillation of mast cell activation is dependent 
upon FcεRI expression or represents an intrinisic change in mast cell state, we used 
ionomycin to activate synchronized BMMCs independent of FcεRI and measured 
cytokine production over 72 hours.  Interestingly, IL-13 mRNA did not display an 
oscillation pattern following ionomycin challenge as observed following IgE/Ag 
stimulation of BMMCs.  This result provides evidence that circadian activation of mast 
cells may be FcεRI-dependent.  
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To further investigate IgE-dependent circadian activation of BMMCs, FcεRI 
expression was measured up to 72 hours. The diurnal variations in FcεRIα expression 
first observed in rat pineal glands suggests a biological significance of the timing of 
receptor function (Ganguly et al., 2007).  Although we cannot formally exclude other 
influences, we speculate that the circadian oscillation of cytokine production in IgE/Ag 
stimulated BMMCs is due to circadian variation in FcεRIα expression. In fact, the IL-13 
mRNA levels observed in this study from IgE/Ag stimulated BMMCs peak at 24 hours 
and 56 hours, when the surface expression of FcεRIα peaks.  Further experiments are 
required to unravel the underlying mechanism and determine which circadian factors 
regulate the oscillation of FcεRIα in BMMCs.  
Even though it appears that the circadian system can influence IgE/Ag activated 
BMMCs, the influence of IgE/Ag stimulation on the phases, phase relations, and 
amplitudes of circadian genes is still unknown in mast cells. Evidence suggests that the 
relationship of the immune system and the circadian system is bidirectional (Coogan et 
al., 2008).  In this study, we show circadian expression of mPer2 can be triggered by 
serum shock but not IgE/Ag stimulation alone.  Meanwhile, the initiated circadian phase 
of mPer2 by serum shock cannot be shifted via IgE/Ag stimulation.  We cannot, 
however, exclude the prolonged effects of IgE/Ag on BMMCs, including the production 
of proinflammatory cytokines, such as TNF-α, which could phase shift the clock in 
BMMCs.  
In conclusion, BMMCs rhythmically express circadian clock genes, and BMMC 
activation through IgE/Ag exhibits a trend towards a circadian pattern which is linked to 
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circadian expression of FcεRIα. The local conserved circadian clock in mast cells begins 
to provide further understanding of the dynamics in allergic disease and in particular 
diseases such as allergic asthma and mastocytosis where diurnal patterns have been 
observed.  By increasing our understanding of the circadian regulation of mast cells, we 
may begin to explore novel therapeutic strategies in the treatment of allergic disease.  
 
 
93 
 
CHAPTER 4: GENERAL DISCUSSION 
 
The present study was undertaken to determine the effects of circadian output on 
nocturnal asthma, and to identify potential mechanisms of circadian rhythm in nocturnal 
asthma by studying the circadian characteristics of mast cells.   
In Aim 1, we used nonhuman primates (NHP), which exhibit a high level of 
similarity to humans in genetic, anatomic, and physiological aspects, and are well suited 
to modeling human diseases such as asthma (Coffman et al., 2005).  The HDM model 
of allergic asthma in Cynomolgus macaques (referred to subsequently as “the NHP 
model”) reproduces the key features of human asthma, including elevated serum IgE 
levels (Table2.1) , β-agonist reversible bronchoconstriction (Figure 2.1), and late phase 
eosinophilic inflammation (Table 2.1) (Van Scott et al., 2004).  In addition, the airways 
become hyperresponsive to nonspecific bronchoconstrictors including histamine, 
methacholine (Table 2.2), and adenosine(Van Scott et al., 2004; Van Scott et al., 2005).  
CD4+ T-lymphocytes and NKT cells in BAL fluid are increased, and Th2 lymphocyte 
cytokines are up-regulated (Ayanoglu et al., 2010).  The severity of the asthma 
phenotype in the NHP model depends on the schedule of allergen challenges and the 
provocative dose of dust mite.  At an exposure periodicity of 4 to 6 week intervals as 
used in this study, the animals have minimal symptoms between exposures, but on the 
day of provocation, exhibit a severe acute asthmatic response, including decrease in 
arterial O2 saturation to less than 80% and in some animals less than 70%.  Upon 
resolution of the acute response the animals develop eosinophilia that is equivalent to 
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what is observed following segmental allergen challenge of asthmatic 
humans(Erpenbeck et al., 2006).  As in humans, the symptoms are attenuated with 
corticosteroids (Van Scott et al., 2004; Ayanoglu et al., 2010).  Extensive terminal 
protocols have not been conducted on these animals, but in a few animals that have 
been examined, airway wall remodeling and mucosal eosinophilia has been observed 
(Van Scott et al., 2004).  These characteristics are consistent with mild to moderate, 
intermittent asthma in humans that is well controlled by β-agonists and corticosteroids. 
In the present study, we used RIP parameters (eBPRL and ePhRL), which 
exhibited a high degree of correlation with the conventional measures of airway 
function, to document the nocturnal asthmatic response in the NHP model of asthma. 
Both eBPRL and ePhRL gradually increase during the night following an early morning 
HDM challenge with a peak around 4 AM (Figure 2.4), which is consistent with the time 
course of nocturnal symptoms in asthmatic patients (Irvin et al., 2000).  Nocturnal 
increase in RIP parameters may therefore be linked to underlying bronchoconstriction.  
To fully verify the nocturnal bronchoconstriction in allergic NHP, however, further 
studies must be conducted. 
To further study nocturnal responses in allergic NHP, nocturnal 
bronchoconstriction ideally should be measured by forced oscillatory technique (Scireq 
Flexivent system) and nocturnal inflammation should be determined by the mediators in 
BAL samples and blood samples when eBPRL and ePhRL peak during the night. The 
forced oscillatory technique determines pulmonary mechanics by superimposing small 
external pressure signals on the spontaneous breathing of the subjects (Oostveen et al., 
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2003). In our study, the measurement of nocturnal bronchoconstriction was conducted 
by forced oscillatory technique as well as RIP.  Unfortunately, animals awakening during 
the night increases stress levels in the subjects. Stress has been considered a powerful 
manipulator in human airway function (Chrousos, 1995) due to the increased release of 
cortisol and epinephrine. Cortisol exerts anti-inflammatory effects and upregulates β-
adrenergic receptor function; epinephrine induces bronchodilation and stabilizes the 
mast cell membrane attenuating the release of proinflammatory mediators (Smolensky 
et al., 2007). In these cohort animals, strong stresses have been found to limit 
inflammation resulting in the attenuation of symptoms for up to 6 months.  In addition to 
the stress produced in animal subjects by awakening, studies in asthmatics with 
nocturnal symptoms have shown that the disturbance of sleep has profound effects on 
nocturnal bronchoconstriction by decreasing airway resistance during the night (Ballard 
et al., 1989).  Therefore, nocturnal bronchoconstriction in allergic NHP could not be 
measured directly by conventional pressure flow analysis or the forced oscillatory 
technique.   
Isolation of mast cells from NHP’s on regular basis was not feasible, and 
therefore we transitioned from a monkey model to a mouse model.  However, as mice 
are nocturnal animals, they are not suitable to study nocturnal asthma.  To further study 
the cellular mechanisms underlying circadian variation in asthma symptoms, bone 
marrow-derived mast cells (BMMCs) were collected from femoral bone marrow in 
C57/BL6 mice and cultured for 4 weeks in vitro. These cells have been dissociated from 
the body, and thus are uninfluenced by nocturnal features of the animals.  Cultured 
BMMCs remain growth factor-dependent (IL-3 dependent), express high levels of c-kit 
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and high-affinity IgE receptor, FcεRI, contain preformed mediators that are present in 
the characteristic granules, and express some inducible mediators. Thus, BMMCs 
provide a powerful tool for investigating the underlying mechanisms of asthma in vitro.   
In Aim 2, serum shock induced periodic expression of circadian genes in BMMCs 
up to 72 hours, which indicated an endogenous circadian clock in BMMCs.  In vitro, 
circadian oscillations have been documented in individual cells of NIH3T3 fibroblast 
lines (Nagoshi et al., 2004). However, self-sustained oscillation in populations of cells is 
unsynchronized and can be synchronized by serum shock(Balsalobre et al., 1998; 
Nagoshi et al., 2004).  In the present study, serum shock synchronized individual 
rhythms in BMMCs to a common phase as does it in fibroblasts (Balsalobre et al., 1998; 
Nagoshi et al., 2004), adipose-derived stem cells (Wu et al., 2007), natural killer cells 
(Murphy et al., 2007), and cardiomyocytes (Durgan et al., 2005). Even though the 
mechanism(s) underlying serum shock synchronization of circadian gene expression in 
vitro is still unclear,  the ability of serum shock is thought to be equivalent to the ability of 
light cycles to entrain the circadian clock in vivo (Hastings et al., 2003). Other than 
serum shock, certain pharmacological substances, including β2 –adrenoceptor agonists 
and dexamethasone, can synchronize the uncoordinated circadian oscillation in cells 
(Takata et al., 2005; Wu et al., 2007; Wu et al., 2008). In our study, we used serum 
shock to synchronize the BMMCs because such pharmacological substances 
synchronize the BMMCs at the expense of proper mast cell functioning.  
The current study has demonstrated that circadian clock genes are not only 
expressed in BMMCs but also oscillate in a circadian pattern following serum shock.  
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The expression of Bmal1 is earlier than the expressions of Rev-erbα and mPer2 
because BMAL1 and CLOCK heterodimers bind to the E-box on the promoter of the 
genes and initiate Rev-erbα and mPer2 expressions. On the other hand, both the 
expressions of Rev-erba and mPer2 inhibit Bmal1 gene expression or BMAL1 protein 
binding with CLOCK, respectively (Figure 4.1). This phase relationship among circadian 
genes in BMMCs is consistent with that in other cell types.  In summary, these findings 
indicate that mast cells contain a local intrinsic clock.  
In Aim 2, we also investigated the effects of the endogenous clock on mast cell 
functions including cytokine production and surface receptor expression. Cytokine levels 
were measured at different time points along the circadian clock gene oscillation. IL-13 
mRNA produced by IgE-dependent activation in synchronized BMMCs showed 
circadian changes in their levels over 72 hours (Figure 3.3 A and B).  However, IL-13 
mRNA produced by ionomycin activated synchronized BMMCs did not exhibit circadian 
changes (Figure 3.3 C and D). These results indicated that cytokine mRNAs, which are 
associated with allergic asthma and are produced by mast cells through an IgE-
dependent pathway, exhibit a trend towards a circadian pattern.   
In human asthma, IL-13 mRNA in BAL cells and IL-13 in BAL fluid are 
significantly increased (Huang et al., 1995). The increased IL-13 is associated 
predominantly with the late asthmatic response and is correlated with eosinophil 
numbers.  In present study, we showed that IL-13 mRNA oscillated in mast cells, which 
are predominant cellular sources of IL-13. Studies have shown that the number of BAL 
cells expressing IL-13 mRNA in nocturnal asthma was increased at 4:00 AM as 
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compared with 4:00 PM (Kraft et al., 2001). The circadian oscillation of IL-13 mRNA in 
mast cells might directly influence nocturnal expression of asthma symptoms in human. 
To further study the mechanism behind the IgE-dependent cytokine mRNA 
oscillation in BMMCs, the surface expression of FcεRIα was measured for up to 72 
hours. Both mRNA levels and protein levels of FcεRIα exhibit periodic oscillation 
following serum shock.  Interestingly, the IL-13 mRNA levels observed in this study from 
IgE/Ag stimulated BMMCs peak at 24 hours and 56 hours, paralleling peak surface 
expression of FcεRIα (Figure 3.3, Figure 3.6 and Figure 3.7).  These results indicate 
that circadian oscillation of IL-13 mRNA following IgE-dependent activation is at least in 
part due to circadian oscillation of FcεRIα. 
However, the cytokine proteins produced by IgE-dependent activation of 
synchronized BMMCs did not show any circadian oscillation due to a 4 hour delay in 
supernatant collection.  In mast cells, IgE receptors can be recruited to cell surface and 
stabilized by exposing the cells to IgE in vitro (Kitaura et al., 2004). This time consuming 
process might diminish the oscillation of receptor surface expression in vitro.  In addition 
to IgE receptor recruitment, 4 hours of cytokine release will lead to an accumulation of 
cytokine levels in the supernatant, perhaps dampening circadian effects on cytokine 
release.  Nevertheless, cytokine mRNA levels were measured in a much shorter period 
than that of protein levels.  Therefore, without time disturbance, the circadian oscillation 
of cytokine mRNA was observed in synchronized BMMC through an IgE-dependent 
pathway.   
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In the current study, we investigated the influence of IgE/Ag simulation on the 
phases, phase relations, and amplitudes of circadian genes.  Previous studies have 
shown that the relationship of the immune system and the circadian system is 
bidirectional (Coogan et al., 2008).  Circadian expression of mPer2 can be triggered by 
serum shock but not IgE/Ag stimulation alone (Figure 3.5).  Meanwhile, the initiated 
circadian phase of mPer2 by serum shock cannot be shifted via IgE/Ag stimulation.  We 
cannot, however, exclude the prolonged effects of IgE/Ag on BMMCs, including the 
production of proinflammatory cytokines, such as TNF-α, which could phase shift the 
clock in BMMCs.  
Overall, this dissertation has increased our understanding of how the circadian 
clock system underlies the nocturnal expression of asthma symptoms (Figure 4.2).  The 
results have provided first direct evidence that the circadian time system in mast cells 
modulates their function.  However, the exact mechanism of circadian variation in mast 
cells directly affects nocturnal asthma need further studies. 
 
Future Studies 
Future studies must be conducted to further characterize the mechanism for 
augmenting nocturnal inflammation in asthmatics. One possibility is the evening 
reduction in cortisol, which may allow the inflammatory cascade to proceed. If the 
technique for remotely drawing the blood is available, we could collect the blood from 
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NHP at different time points to study the serum cortisol levels without disturbing the 
animals.    
In our study, we demonstrate an effect of time of day on cytokine production and 
receptor expression in mast cells, but it is still unknown whether these time-dependent 
effects are induced directly by a local endogenous circadian clock. To answer this 
question, we would need knockout/knockdown circadian clock genes to determine 
whether there is a phase shift or attenuated expression of cytokines or receptor. 
To further prove the effects of the mast cell circadian clock on nocturnal asthma 
in vivo, lung mast cells in NHP need to be studied by sacrificing animals and analyzing 
the circadian clock in lung tissues. However, it is too expensive to conduct such 
experiments. Alternatively, if the technique for remotely drawing the blood is available, 
basophils, which share many features with mast cells such as expression of FcεRI 
(Stone et al., 2010), could be collected through blood and studied for circadian effects 
on nocturnal asthma.   
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Figure 4.1 Schematic representation of molecular circadian clock in mast cell 
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Figure 4.2 Circadian outputs from mast cells mediate nocturnal symptoms in 
asthma 
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Modified from Esquifino et al., 2007 
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